Amended and Restated Severance and Change of Control AgreementControl Agreement • August 8th, 2023 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 8th, 2023 Company Industry JurisdictionThis Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of [ ] (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and [ ] (“Employee”).
AMENDMENT NO. 3 TO THE COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • August 8th, 2023 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2023 Company Industry JurisdictionThis Amendment No. 3 to the Collaboration Agreement (this “Amendment”) is effective as of the 18th day of May, 2023 (the “Amendment Effective Date”) by and between Amgen Inc., a Delaware corporation having an address at One Amgen Center Drive, Thousand Oaks, California 91320 (“Amgen”) and CytomX Therapeutics, Inc., a Delaware corporation having an address at 151 Oyster Point Blvd., Suite 400, South San Francisco, California 94080 (“CytomX”). Amgen and CytomX are each hereafter referred to individually as a “Party” and together as the “Parties”.